Efficacy of Acupuncture Is Noninferior to Nicotine Replacement Therapy for Tobacco Cessation Results of a Prospective, Randomized, Active-Controlled Open-Label Trial

被引:19
作者
Wang, Ying-ying [1 ]
Liu, Zhao [2 ,3 ]
Wu, Yuan [4 ]
Yang, Li [1 ]
Guo, Lang-tao [5 ]
Zhang, Hao-bin [6 ]
Yang, Jin-sheng [1 ]
机构
[1] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing 100070, Peoples R China
[2] China Japan Friendship Hosp, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China
[3] WHO Collaborating Ctr Tobacco Cessat & Resp Dis P, Beijing, Peoples R China
[4] China Assoc Acupuncture & Moxibust, Beijing, Peoples R China
[5] Xian Encephalopathy Hosp Tradit Chinese Med, Xian, Shaanxi, Peoples R China
[6] Shaanxi Univ TCM, Coll Acupuncture & Moxibust, Xian, Shaanxi, Peoples R China
关键词
acupuncture; nicotine replacement therapy; randomized controlled trial; tobacco cessation; SMOKING-CESSATION;
D O I
10.1016/j.chest.2017.11.015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: We designed and conducted this multicenter randomized active-controlled open-label trial to evaluate the efficacy of acupuncture, auricular point pressing, and nicotine replacement therapy (NRT) on tobacco cessation in the Chinese population. METHODS: This randomized controlled trial was conducted in seven hospitals in China between October 2013 and February 2016. Eligible participants were recruited and randomly assigned to receive acupuncture or auricular point pressing or NRT via a central randomization system with a 1:1:1 ratio. All treatment was given for a total of 8 weeks, and follow-up visit was at 16 weeks. The primary outcome measure was carbon monoxide (CO)-confirmed 24-h point abstinence rate (<10 parts per million), 24 weeks after quit day. RESULTS: A total of 300 participants were recruited and 195 participants finished, with a dropout rate of 35.00%. Two cases of adverse events in the acupuncture group and 2 cases in the NRT group were observed. The CO-confirmed 24-h point abstinence rate was 43.00% at 24 weeks in the acupuncture group, which was similar to 44.00% in the NRT group (P > .05), but significantly higher than the 30.00% in the auricular point group (P < .05). At 24 weeks, the Fagerstrom Nicotine Dependence Test and the Minnesota Nicotine Withdrawal Scale scores in the acupuncture group were significantly lower than those in the auricular point group and in the NRT group (P < .05). Kaplan-Meier analysis showed the time to relapse for acupuncture (44.12 days) was insignificantly longer than NRT (41.18 days), but significantly longer than auricular point pressing (29.53 days). CONCLUSIONS: We found acupuncture was safe and a possible treatment for tobacco cessation, but it requires further study to establish its role.
引用
收藏
页码:680 / 688
页数:9
相关论文
共 50 条
  • [21] Clinical Effectiveness of Traditional and Complementary Medicine Interventions in Combination with Nicotine Replacement Therapy on Smoking Cessation: A Randomized Controlled Pilot Trial
    Jang, Soobin
    Lee, Ju Ah
    Jang, Bo-Hyoung
    Shin, Yong-Cheol
    Ko, Seong-Gyu
    Park, Sunju
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (05) : 526 - 534
  • [22] Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial
    Carpenter, Matthew J.
    Wahlquist, Amy E.
    Dahne, Jennifer
    Gray, Kevin M.
    Garrett-Mayer, Elizabeth
    Cummings, K. Michael
    Davis, Robert
    Egan, Brent M.
    ADDICTION, 2020, 115 (07) : 1358 - 1367
  • [23] Open-Label Placebo Treatment for Experimental Pain: A Randomized-Controlled Trial with Placebo Acupuncture and Placebo Pills
    Lee, Seoyoung
    Choi, Dha-Hyun
    Hong, Minyoung
    Lee, In-Seon
    Chae, Younbyoung
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2022, 28 (02): : 136 - 145
  • [24] Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial
    Nomura, Akihiro
    Tanigawa, Tomoyuki
    Muto, Tomoyasu
    Oga, Takafumi
    Fukushima, Yasushi
    Kiyosue, Arihiro
    Miyazaki, Masaki
    Hida, Eisuke
    Satake, Kohta
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (04)
  • [25] Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial
    Li Yu
    Xiong Chan
    Zeng Yan
    Wei Hua
    Zhuang Guangtong
    Zhao Lihong
    Li Chenyi
    Li Lin
    Qin Erqi
    Chen Xiaoqin
    Fu Juanjuan
    Journal of Traditional Chinese Medicine, 2019, 39 (06) : 885 - 891
  • [26] Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial
    Li Yu
    Xiong Chan
    Zeng Yan
    Wei Hua
    Zhuang Guangtong
    Zhao Lihong
    Li Chenyi
    Li Lin
    Qin Erqi
    Chen Xiaoqin
    Fu Juanjuan
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2019, 39 (06) : 885 - 891
  • [27] Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial
    Sifat, Munjireen
    Hebert, Emily
    Ahluwalia, Jasjit S.
    Businelle, Michael S.
    Waring, Joseph J. C.
    Frank-Pearce, Summer G.
    Bryer, Chase
    Benson, Lizbeth
    Madison, Stefani
    Planas, Lourdes G.
    Baranskaya, Irina
    Kendzor, Darla E.
    JMIR FORMATIVE RESEARCH, 2023, 7
  • [28] Is stress management training a useful addition to physician advice and nicotine replacement therapy during smoking cessation in women? Results of a randomized trial
    D'Angelo, MES
    Reid, RD
    Holz, S
    Irvine, J
    Segal, RJ
    Blanchard, CM
    Pipe, A
    AMERICAN JOURNAL OF HEALTH PROMOTION, 2005, 20 (02) : 127 - 134
  • [29] Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial
    Howard, Bridget C.
    McRobbie, Hayden
    Petrie, Dennis
    Barker, Daniel
    Mendelsohn, Colin
    Anderson, Jack
    Borland, Ron
    Naughton, Felix
    Tutka, Piotr
    Zwar, Nick
    Boland, Veronica C.
    Aiken, Alexandra
    Shakeshaft, Anthony
    Gartner, Coral
    Richmond, Robyn L.
    Hall, Wayne
    Mattick, Richard P.
    Farrell, Michael
    Courtney, Ryan J.
    TRIALS, 2022, 23 (01)
  • [30] Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial
    Bridget C Howard
    Hayden McRobbie
    Dennis Petrie
    Daniel Barker
    Colin Mendelsohn
    Jack Anderson
    Ron Borland
    Felix Naughton
    Piotr Tutka
    Nick Zwar
    Veronica C Boland
    Alexandra Aiken
    Anthony Shakeshaft
    Coral Gartner
    Robyn L Richmond
    Wayne Hall
    Richard P Mattick
    Michael Farrell
    Ryan J Courtney
    Trials, 23